Globalpharma Partners with ZIM Laboratories

Globalpharma, the UAE’s leading pharmaceutical
manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has
collaborated with India’s ZIM Laboratories to bring EU-certified Oral Dispersible Film
(ODF) technology to its growing portfolio. This innovative drug technology has
already received EU Good Manufacturing Practice (EU-GMP) certification, ensuring
it meets the highest international quality and safety standards.
The agreement, unveiled at AIM Congress 2025 (7-9 April), underscores the UAE’s
growing influence in global pharmaceutical innovation and its commitment to cutting-
edge healthcare solutions.

The signing ceremony, witnessed by H.E. Dr. Thani bin Ahmed Al Zeyoudi, Minister
of State for Foreign Trade and Chairman of the Board of Emirates Drug
Establishment (EDE), was signed by Mohammed Saeed Al Raqbani, General
Manager of Dubai Investments Industries and Masharie and Board Director at
Globalpharma and Zulfiquar Kamal, Promoter & Finance Director at ZIM Labs in the
presence of Dr. Mariam Galadari, Board Member, Globalpharma.
Reinforcing Globalpharma’s thought leadership at AIM Congress 2025, Dr. Basem
Al-Barahmeh, Globalpharma’s General Manager, delivered a compelling keynote on
the UAE’s emergence as a pharmaceutical manufacturing powerhouse.